University Of Vermont's Pharmacology Course Breaks New Ground

Warning message

The subscription service is currently unavailable. Please try again later.

It’s a formidable challenge to develop a syllabus for a college-level pharmacology course focused entirely on a drug that’s illegal to possess, use and even research under federal law. That’s the task that Wolfgang Dostmann, PhD, and Karen Lounsbury, PhD, have undertaken as they plan the University of Vermont’s first medical cannabis course in the College of Medicine’s Department of Pharmacology, scheduled for the spring 2016 semester. It’s possibly the first academic program of its kind nationwide, but clearly needed as acceptance of marijuana for medical and recreational use continues to gain legal backing in more states and physicians and scientists seek more information about how it acts in the body.

The two UVM pharmacology professors have had limited scientific sources or reputable studies to guide them. The lack of federal legalization has meant that no major U.S. sources of funding – the National Science Foundation or the National Institutes...

Rate this article: 

This marijuana news is brought to you by 420 Intel. For the latest breaking cannabis industry news, subscribe to the 420 Intel newsletter. If you'd like to promote your product or service in this area after every article, contact us.